We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Urges Drug Sponsors to Reduce Uncertainties to Help Its Benefit-Risk Assessments
FDA Urges Drug Sponsors to Reduce Uncertainties to Help Its Benefit-Risk Assessments
The FDA encourages sponsors of new drug and biological products to take steps to reduce uncertainties that can affect the agency’s benefit-risk assessments, in a new guidance released yesterday.